IRCT2016080829257N1招募中1 期
Immunotherapy of pediatric patients with brain tumor using autologous tumor - lysate pulsed dendritic cells in a phase I/II clinical trial
rmia University of Medical Science0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 15 years（—）
- 性别
- All
入选标准
- •Brain tumor without metastases or recurrence; glioma; meduloblastoma; CD4>350 cell/mm; 3-18 months = age =15 years; 10Kg =Weight; Confirmation of informed consent; Normal serum tests; Immunotherapy should be started at least 3 wks after last chemo or radiotherapy course
- •Exclusion criteria:
- •Cardiovascular-pulmnary diseases; Hepatitis B, C or HIV infections; tumor pressure on spinal cord; Patient who will need chemo or radiotherapy during immunotherapy; 470ms=Improved QT; ECG disorders; corticosteroides administration
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Immunochemotherapy in primary central nervous system lymphoma with rituximab, HD-MTX, HD Ara-C, cyclophosphamide, ifosfamide, vincristine, vindesine, temozolomide,and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomide - NLG PCNSEUCTR2006-004772-12-FIordic lymphoma group70
进行中（未招募）
不适用
Immunochemotherapy in primary central nervous system lymphoma with Rituximab, HD-MTX, HD-Ara C, cyclophosphamide, ifosfamide, vincristine, vindesine, temozolomide and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomide.ewly diagnosed Primary Central Nervous LymphomaEUCTR2006-004772-12-SEordic Lymphoma Group70
进行中（未招募）
1 期
Immunochemotherapy in Primary Central Nervous System Lymphoma with Rituximab, HD-MTX, HD-Ara C, cyclophosphamide, ifosfamide, vincristine, vindesine, temozolomide and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomide.ewly diagnosed Primary Central Nervous LymphomaMedDRA version: 8.1Level: PTClassification code 10007953Term: Central nervous system lymphomaEUCTR2006-004772-12-DKordic Lymphoma Group70
招募中
2 期
Chemoimmunotherapy in conjunction with blood-brain-barrier opening in patients with newly diagnosed or relapsed primary central nervous system lymphoma2024-519046-79-00Oulu University Hospital100
已完成
1 期
MGMT Gene Therapy and Chemotherapy for the treatment of Childhood Brain TumoursChildhood Brain TumoursCancer - BrainACTRN12612000535875The Sydney Children's Hospital Network12